Rhythm Pharmaceuticals (RYTM) Other Non-Current Assets (2016 - 2026)

Rhythm Pharmaceuticals (RYTM) has 11 years of Other Non-Current Assets data on file, last reported at $601000.0 in Q1 2026.

• On a quarterly basis, Other Non-Current Assets rose 29.53% year-over-year to $601000.0 in Q1 2026; TTM through Mar 2026 was $601000.0, a 29.53% increase from a year earlier, with the FY2025 full-year figure at $522000.0, up 12.5% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $601000.0, up from $522000.0 in the prior quarter.
• Over the last five years, Other Non-Current Assets for RYTM reached as high as $671000.0 in Q3 2025 and fell as low as $328000.0 in Q1 2022.
• Historically, Other Non-Current Assets has averaged $426764.7 across 5 years, with a median of $460000.0 in 2024.
• Across the five-year window, Other Non-Current Assets changed 0.0% in 2022 and soared 45.24% in 2025, its largest moves.
• Year by year, Other Non-Current Assets stood at $328000.0 in 2022, then changed by 0.0% to $328000.0 in 2023, then surged by 41.46% to $464000.0 in 2024, then gained by 12.5% to $522000.0 in 2025, then rose by 15.13% to $601000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $601000.0 in Q1 2026, $522000.0 in Q4 2025, and $671000.0 in Q3 2025.